{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:01:14Z","timestamp":1790200874981,"version":"4.1.0"},"reference-count":37,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3892\/ol.2014.2144","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T08:16:00Z","timestamp":1399968960000},"page":"230-234","source":"Crossref","is-referenced-by-count":29,"title":["Multiple endocrine neoplasia type 1 associated with breast cancer: A case report and review of the literature"],"prefix":"10.3892","volume":"8","author":[{"given":"YOUNG JU","family":"JEONG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HOON KYU","family":"OH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN GU","family":"BONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,5,13]]},"reference":[{"key":"key20180108104754_b1-ol-08-01-0230","first-page":"105","article-title":"Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis","volume":"79","author":"Busygina","year":"2006","journal-title":"Yale J Biol Med"},{"key":"key20180108104754_b2-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"key20180108104754_b3-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/332085a0","article-title":"Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma","volume":"332","author":"Larsson","year":"1988","journal-title":"Nature"},{"key":"key20180108104754_b4-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJM198907273210403","article-title":"Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11","volume":"321","author":"Thakker","year":"1989","journal-title":"N Engl J Med"},{"key":"key20180108104754_b5-ol-08-01-0230","first-page":"2627","article-title":"Alterations of the MEN1 gene in sporadic parathyroid tumors","volume":"83","author":"Farnebo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108104754_b6-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108104754_b7-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"705036","DOI":"10.1155\/2012\/705036","article-title":"Genetic and clinical features of multiple endocrine neoplasia types 1 and 2","volume":"2012","author":"Romei","year":"2012","journal-title":"J Oncol"},{"key":"key20180108104754_b8-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/eje.0.1420131","article-title":"MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1","volume":"142","author":"Morelli","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"key20180108104754_b9-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/1050725042451220","article-title":"RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A","volume":"14","author":"Chung","year":"2004","journal-title":"Thyroid"},{"key":"key20180108104754_b10-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbrc.2006.08.086","article-title":"Identification of BRCA1 and BRCA2 mutations from Korean breast cancer patients using denaturing HPLC","volume":"349","author":"Kim","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108104754_b11-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/301953","article-title":"Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders","volume":"63","author":"Giraud","year":"1998","journal-title":"Am J Hum Genet"},{"key":"key20180108104754_b12-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2169\/internalmedicine.43.310","article-title":"Primary hyperparathyroidism associated with aldosterone-producing adrenocortical adenoma and breast cancer: Relation to MEN1 gene","volume":"43","author":"Honda","year":"2004","journal-title":"Intern Med"},{"issue":"suppl","key":"key20180108104754_b13-ol-08-01-0230","article-title":"Breast cancer in a patient with multiple endocrine neoplasia type 1 (MEN1): A case report and review of the literature","volume":"30","author":"Inic","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180108104754_b14-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cancergencyto.2009.06.019","article-title":"Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report","volume":"195","author":"Papi","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"key20180108104754_b15-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2007.08.009","article-title":"A carrier or both MEN1 and BRCA2 mutations: case report and review of the literature","volume":"179","author":"Ghataorhe","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"key20180108104754_b16-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1365-2796.2003.01165.x","article-title":"Functional studies of the MEN1 gene. Functional studies of the MEN1 gene","volume":"253","author":"Chandrasekharappa","year":"2003","journal-title":"J Intern Med"},{"key":"key20180108104754_b17-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108104754_b18-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"key20180108104754_b19-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archsurg.137.6.641","article-title":"Genotype-phenotype analysis in multiple endocrine neoplasia type 1","volume":"137","author":"Kouvaraki","year":"2002","journal-title":"Arch Surg"},{"issue":"Suppl 1","key":"key20180108104754_b20-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6061\/clinics\/2012(Sup01)10","article-title":"Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation","volume":"67","author":"Lips","year":"2012","journal-title":"Clinics (Sao Paolo)"},{"key":"key20180108104754_b21-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2005.02190.x","article-title":"Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing","volume":"62","author":"Ellard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20180108104754_b22-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.GIM.0000153663.62300.F8","article-title":"Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory","volume":"7","author":"Klein","year":"2005","journal-title":"Genet Med"},{"key":"key20180108104754_b23-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1399-0004.2003.00091.x","article-title":"Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders","volume":"64","author":"Park","year":"2003","journal-title":"Clin Genet"},{"key":"key20180108104754_b24-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)80967-8","article-title":"Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription","volume":"96","author":"Agarwal","year":"1999","journal-title":"Cell"},{"key":"key20180108104754_b25-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/sj.onc.1204529","article-title":"The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation","volume":"20","author":"Heppner","year":"2001","journal-title":"Oncogene"},{"key":"key20180108104754_b26-ol-08-01-0230","first-page":"6135","article-title":"Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"issue":"Suppl 1","key":"key20180108104754_b27-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"187s","DOI":"10.1016\/S0753-3322(00)80041-4","article-title":"Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1","volume":"54","author":"Itakura","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"key20180108104754_b28-ol-08-01-0230","first-page":"4204","article-title":"Menin associates with FANCD2, a protein involved in repair of DNA damage","volume":"63","author":"Jin","year":"2003","journal-title":"Cancer Res"},{"key":"key20180108104754_b29-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.dnarep.2004.03.028","article-title":"Replication protein A phosphorylation and the cellular response to DNA damage","volume":"3","author":"Binz","year":"2004","journal-title":"DNA Repair (Amst)"},{"key":"key20180108104754_b30-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1038\/sj.onc.1203005","article-title":"Stable overexpression of MEN1 suppresses tumorigenicity of RAS","volume":"18","author":"Kim","year":"1999","journal-title":"Oncogene"},{"key":"key20180108104754_b31-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-05-4461","article-title":"Menin links estrogen receptor activation to histone H3K4 trimethylation","volume":"66","author":"Dreijerink","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108104754_b32-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1096\/fj.01-0498fje","article-title":"The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells","volume":"16","author":"Prest","year":"2002","journal-title":"FASEB J"},{"key":"key20180108104754_b33-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-005-9041-7","article-title":"Cytosolic levels of TFF1\/pS2 in breast cancer: Their relationship to clinical-pathological parameters and their prognostic significance","volume":"96","author":"Corte","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"key20180108104754_b34-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/onc.2011.41","article-title":"Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice","volume":"30","author":"Bauche","year":"2011","journal-title":"Oncogene"},{"key":"key20180108104754_b35-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1210\/en.2009-0066","article-title":"Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells","volume":"150","author":"Amiry","year":"2009","journal-title":"Endocrinology"},{"key":"key20180108104754_b36-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00666592","article-title":"Expression of the pS2 gene in normal breast tissue","volume":"28","author":"H\u00e4hnel","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"key20180108104754_b37-ol-08-01-0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K","article-title":"Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium","volume":"183","author":"Poulsom","year":"1997","journal-title":"J Pathol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2014.2144\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T07:47:56Z","timestamp":1565423276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2014.2144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,5,13]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3892\/ol.2014.2144"],"URL":"https:\/\/doi.org\/10.3892\/ol.2014.2144","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,13]]}}}